Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-30 · accession 0001209191-21-044423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-30 | KPTI | Cheng Sohanya Roshan | SVP Sales, Commercial Ops | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
| D | 2021-07-01 | 2021-06-30 | KPTI | Cheng Sohanya Roshan | SVP Sales, Commercial Ops | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | A | A | 7,500 | $0.00 | 7,500 | D | — | — | (F1) Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on June 7, 2022, the first anniversary of Ms. Cheng's date of hire, with the remaining 50% vesting on June 7, 2023. |
| 2 | Derivative | Nonstatutory Stock Option (right to buy) | 2021-06-30 | A | A | 125,000 | $0.00 | 125,000 | D | $10.32 · — to 2031-06-29 | 125,000 Common Stock | (F2) This option was granted on June 30, 2021. The shares underlying this option vest as to 25% of the shares on June 30, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter. |